General Characteristics of HHV-6 and HHV-7
Human herpesviruses 6 and 7 belong to the genus Roseolovirus. Their key feature is marked lymphotropism—the pathogens selectively infect and replicate in human T lymphocytes.
Human herpesvirus 6 (HHV-6), also known as Herpes lymphotropic virus, is widespread in the human population and shares significant biological properties with Epstein-Barr virus (EBV) and cytomegalovirus (CMV). There are two main variants: HHV-6A and HHV-6B. The virus was first isolated in 1986 by a research group led by R. Gallo from lymphocytes of patients with lymphoproliferative disorders and AIDS.
The pathogenesis of the infection is typical for this family: following primary infection, the virus enters a latent state. It persistently resides in the salivary glands, which allows for active shedding in saliva. In the event of immunosuppression, the virus reactivates, leading to clinical manifestations.
Human herpesvirus 7 (HHV-7) was isolated later, in 1990, by Dr. Frenkel. Unlike type 6, the virus was initially discovered in T lymphocytes of completely healthy individuals. However, its association with chronic fatigue syndrome and AIDS was later established. HHV-7 causes pathological processes analogous to those provoked by HHV-6, but generally with a milder clinical presentation.
Clinical Manifestations of HHV-6
Infection caused by HHV-6 typically presents in two main forms:
- Exanthema subitum (also known as roseola infantum or the sixth disease). This is a classic pediatric infection predominantly affecting infants aged 6 months to 3 years. The disease begins with a sudden, rapid spike in body temperature up to 40 °C (104 °F). This high fever persists for precisely three days, after which the temperature rapidly drops to normal, and a characteristic maculopapular rash appears on the trunk and neck.
- Chronic fatigue syndrome. Occurs in adults and adolescents. Clinical features include prolonged low-grade fever, severe night sweats, arthralgia, persistent fatigue, and generalized lymphadenopathy.
Characteristics of HHV-8 (Kaposi Sarcoma-Associated Herpesvirus)
The eighth human herpesvirus type was discovered in 1994. Researchers identified specific viral DNA sequences directly within Kaposi sarcoma tissue samples from HIV-positive patients. Since then, HHV-8 has been recognized as the primary etiologic agent of this malignancy.
A distinguishing feature of this virus is its neuroinvasiveness—the ability to penetrate and persist within structures of the nervous system. The localization of the virus depends on the patient's immune status:
- In patients with Kaposi sarcoma, the virus is detected in dorsal root ganglia.
- In HIV-infected patients, the pathogen is frequently isolated from cerebrospinal fluid (CSF).
For diagnosing HHV-8, traditional viral culture methods are rarely used; polymerase chain reaction (PCR) serves as the gold standard and primary method of detection.
Laboratory Diagnostics of HHV-6 and HHV-7
A comprehensive approach is used in microbiology to confirm infections caused by the genus Roseolovirus:
- Virological method (culture). Peripheral blood lymphocytes are obtained from the patient and co-cultivated with mitogen-activated lymphocytes. Viral replication is identified by a characteristic cytopathic effect (CPE)—the formation of large multinucleated syncytia. Direct isolation from saliva samples is also possible.
- Serological method (ELISA). Aimed at detecting specific antibodies in blood serum. The detection of immunoglobulin M (IgM) antibodies serves as a reliable marker of acute infection.
- Molecular-biological method (PCR). Used for high-precision detection of viral marker genes in various biological fluids.
Treatment Approaches
Therapy for infections caused by these herpesviruses relies on pharmacological principles similar to those used for classic herpesvirus infections. Two main groups of drugs are utilized:
- Nucleoside analogs. Ganciclovir and foscarnet are considered the most effective agents. They incorporate into the viral replication cycle and inhibit viral DNA synthesis.
- Immunomodulators. Various interferon preparations are frequently prescribed to support the host immune system and suppress viral replication.